Top Targeted Therapeutics Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Targeted Therapeutics Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Targeted Therapeutics industry players.

Targeted Therapeutics Market Competitive Landscape

Global targeted therapeutics market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global targeted therapeutics market.

For example, on July 21, 2021, United Kingdom-based pharmaceutical giant AstraZeneca announced that it had closed the acquisition process for US-based biopharmaceutical company, Alexion Pharmaceuticals. AstraZeneca paid Alexion USD 39 billion. The move will give AstraZeneca an opportunity to expand its expertise in immunology and in rare medicines.

Top Player's Company Profiles

  • Roche Holding AG
  • Novartis AG
  • Amgen Inc.
  • AstraZeneca Plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • AbbVie Inc.
  • Biogen Inc.
  • Sanofi S.A.
  • Johnson & Johnson
  • Takeda Pharmaceutical Co. Ltd.
  • Gilead Sciences Inc.
  • Vertex Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
  • Regeneron Pharmaceuticals Inc.

Recent Developements

  • In January 2024, Remix Therapeutics started a strategic collaboration with Roche, which is pointed toward utilizing RNA modulation for novel drug discovery efforts.
  • In October 2023, Medilink Therapeutics uncovered a strategic collaboration and overall license agreement with BioNTech to advance the improvement of the cutting-edge enemy of cancer antibody drug forms.
  • In October 2023, Monte Rosa Therapeutics disclosed a strategic collaboration with Roche to discover novel molecular glue degraders targeting malignant growth and neurological diseases.
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Targeted Therapeutics Market size was valued at USD 75.25 Billion in 2024 and is poised to grow from USD 77.36 Billion in 2025 to USD 96.48 Billion by 2033, growing at a CAGR of 2.8% during the forecast period (2026–2033). 

Global targeted therapeutics market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global targeted therapeutics market. 'Roche (Switzerland) ', 'Novartis (Switzerland) ', 'Pfizer (USA) ', 'Merck & Co. (USA) ', 'Bristol-Myers Squibb (USA) ', 'AstraZeneca (UK) ', 'Amgen (USA) ', 'GlaxoSmithKline (UK) ', 'Sanofi (France) ', 'Bayer (Germany) ', 'Eli Lilly and Company (USA) ', 'Johnson & Johnson (USA) ', 'AbbVie (USA) ', 'Takeda Pharmaceutical (Japan) ', 'Gilead Sciences (USA) ', 'Biogen (USA) ', 'Regeneron Pharmaceuticals (USA) ', 'Celgene (USA) (Acquired by Bristol-Myers Squibb) ', 'Incyte (USA) ', 'In January 2024, Remix Therapeutics started a strategic collaboration with Roche, which is pointed toward utilizing RNA modulation for novel drug discovery efforts.', 'In October 2023, Medilink Therapeutics uncovered a strategic collaboration and overall license agreement with BioNTech to advance the improvement of the cutting-edge enemy of cancer antibody drug forms.', 'In October 2023, Monte Rosa Therapeutics disclosed a strategic collaboration with Roche to discover novel molecular glue degraders targeting malignant growth and neurological diseases.'

Increasing prevalence of cancer and disposable income of people

Major players in the global therapeutics market are heavily involved in collaboration agreements and acquisitions as well as new product launches. These initiatives are expected to fuel the growth of the global therapeutics market. Some key competitors in the therapeutics market have adopted expansion strategies. For example, PubMed Inc. has launched its upgraded versions of complement-targeted therapies to cater to various destructive potentials for several diseases and pathological conditions, boosting the sales of complement-targeted therapies.

On the basis of region, global targeted therapeutics market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the global market. This is because the biologics industry in North America is expanding rapidly. The presence of various biotechnology companies in this sector has contributed significantly to the growth of the market. Also, increased investment, along with government support for the development and expansion of biopharmaceutical manufacturing facilities, is expected to boost the targeted therapeutics market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Cancer Therapeutics Market
Buy Now GET FREE SAMPLE
Protein Therapeutics Market
Buy Now GET FREE SAMPLE
Breast Cancer Therapeutics Market
Buy Now GET FREE SAMPLE
mRNA Therapeutics Market
Buy Now GET FREE SAMPLE
Peptide Therapeutics Market
Buy Now GET FREE SAMPLE
Prostate Cancer Therapeutics Market
Buy Now GET FREE SAMPLE
Cancer Biological Therapy Market
Buy Now GET FREE SAMPLE
Targeted Liposomes Drug Delivery Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Targeted Therapeutics Market
Targeted Therapeutics Market

Report ID: SQMIG35H2052

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE